Home › Therapeutic areas › Oncology › Small Cell Lung Cancer

Small Cell Lung Cancer (9 companies)

Companies with an active program in Small Cell Lung Cancer.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ACRV Acrivon Therapeutics GI/HepatologyOncology Rare 1 Phase 2 $61.4M 9
AKTS Aktis Oncology Oncology 1 Phase 1 $910M 10
ALLO Allogene Therapeutics ImmunologyOncology Rare 1 Phase 2 $256M 10
CMPX Compass Therapeutics Oncology 1 Phase 2 $109M 15
GNLX Genelux Oncology 1 Phase 3 $96.1M 3
IDYA IDEAYA Biosciences Oncology 2 NDA Submitted $2.65B 15
LEGN Legend Biotech Oncology Rare 1 Approved $3.12B 17
MAIA MAIA Biotechnology Oncology 1 Phase 3 $77.2M 8
ZYME Zymeworks OncologyRespiratory 1 Approved $1.78B 12